MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages - PubMed (original) (raw)
. 2008 Feb;294(2):G452-9.
doi: 10.1152/ajpgi.00077.2007. Epub 2007 Nov 21.
Affiliations
- PMID: 18032482
- DOI: 10.1152/ajpgi.00077.2007
Free article
MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
Robert M Rowlett et al. Am J Physiol Gastrointest Liver Physiol. 2008 Feb.
Free article
Abstract
The MNK kinases are downstream of both the p38 and ERK MAP kinase pathways and act to increase gene expression. MNK inhibition using the compound CGP57380 has recently been reported to inhibit tumor necrosis factor (TNF) production in macrophage cell lines stimulated with Escherichia coli lipopolysaccharide (LPS). However, the range of receptors that signal through the MNK kinases and the extent of the resultant cytokine response are not known. We found that TNF production was inhibited in RAW264.7 macrophage cells by CGP57380 in a dose-responsive manner with agonists for Toll-like receptor (TLR) 2 (HKLM), TLR4 (Salmonella LPS), TLR6/2 (FSL), TLR7 (imiquimod), and TLR9 (CpG DNA). CGP57380 also inhibited the peak of TNF mRNA production and increased the rate of TNF mRNA decay, effects not due to the destabilizing RNA binding protein tristetraprolin (TTP). Similar to its effects on TNF, CGP57380 caused dose-responsive inhibition of TTP production from stimulation with either LPS or CpG DNA. MNK inhibition also blocked IL-6 but permitted IL-10 production in response to LPS. Studies using bone marrow-derived macrophages (BMDM) isolated from a spontaneous mouse model of Crohn's disease-like ileitis (SAMP1/YitFc strain) revealed significant inhibition by CGP57380 of the proinflammatory cytokines TNF, IL-6, and monocyte chemoattractant protein-1 at 4 and 24 h after LPS stimulation. IL-10 production was higher in CGP53870-treated BMDM at 4 h but was similar to the controls by 24 h. Taken together, these data demonstrate that MNK kinases signal through a variety of TLR agonists and mediate a potent innate, proinflammatory cytokine response.
Similar articles
- Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo.
Fraser CK, Lousberg EL, Kumar R, Hughes TP, Diener KR, Hayball JD. Fraser CK, et al. Exp Hematol. 2009 Dec;37(12):1435-44. doi: 10.1016/j.exphem.2009.09.007. Epub 2009 Sep 26. Exp Hematol. 2009. PMID: 19786067 - MNK as a potential pharmacological target for suppressing LPS-induced acute lung injury in mice.
Gao J, Teng L, Yang S, Huang S, Li L, Zhou L, Liu G, Tang H. Gao J, et al. Biochem Pharmacol. 2021 Apr;186:114499. doi: 10.1016/j.bcp.2021.114499. Epub 2021 Mar 4. Biochem Pharmacol. 2021. PMID: 33675774 Free PMC article. - The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.
Seidel P, Sun Q, Costa L, Lardinois D, Tamm M, Roth M. Seidel P, et al. Cell Signal. 2016 Oct;28(10):1555-62. doi: 10.1016/j.cellsig.2016.07.004. Epub 2016 Jul 11. Cell Signal. 2016. PMID: 27418099 - Macrophage-derived IL-18 targeting for the treatment of Crohn's disease.
Kanai T, Uraushihara K, Totsuka T, Okazawa A, Hibi T, Oshima S, Miyata T, Nakamura T, Watanabe M. Kanai T, et al. Curr Drug Targets Inflamm Allergy. 2003 Jun;2(2):131-6. doi: 10.2174/1568010033484250. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561165 Review. - Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity.
Pham TND, Spaulding C, Munshi HG. Pham TND, et al. Cancers (Basel). 2020 Jul 28;12(8):2096. doi: 10.3390/cancers12082096. Cancers (Basel). 2020. PMID: 32731503 Free PMC article. Review.
Cited by
- Oncology Drug Repurposing for Sepsis Treatment.
Rumienczyk I, Kulecka M, Statkiewicz M, Ostrowski J, Mikula M. Rumienczyk I, et al. Biomedicines. 2022 Apr 17;10(4):921. doi: 10.3390/biomedicines10040921. Biomedicines. 2022. PMID: 35453671 Free PMC article. Review. - The kinase activity of interleukin-1 receptor-associated kinase 2 is essential for lipopolysaccharide-mediated cytokine and chemokine mRNA stability and translation.
Yin W, Wan Y, Kim TW, Yao P, Xiao H, Zhou H, Xiao J, Fox P, Li X. Yin W, et al. J Interferon Cytokine Res. 2011 May;31(5):415-22. doi: 10.1089/jir.2010.0094. Epub 2011 Feb 3. J Interferon Cytokine Res. 2011. PMID: 21291324 Free PMC article. - Using Imidazo[2,1-b][1,3,4]thiadiazol Skeleton to Design and Synthesize Novel MNK Inhibitors.
Jin X, Qiu T, Xie J, Wei X, Wang X, Yu R, Proud C, Jiang T. Jin X, et al. ACS Med Chem Lett. 2022 Dec 15;14(1):83-91. doi: 10.1021/acsmedchemlett.2c00442. eCollection 2023 Jan 12. ACS Med Chem Lett. 2022. PMID: 36655132 Free PMC article. - Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
Poulsen KL, Albee RP, Ganey PE, Roth RA. Poulsen KL, et al. J Pharmacol Exp Ther. 2014 May;349(2):185-91. doi: 10.1124/jpet.113.211276. Epub 2014 Feb 13. J Pharmacol Exp Ther. 2014. PMID: 24525298 Free PMC article. - Mnk kinase pathway: Cellular functions and biological outcomes.
Joshi S, Platanias LC. Joshi S, et al. World J Biol Chem. 2014 Aug 26;5(3):321-33. doi: 10.4331/wjbc.v5.i3.321. World J Biol Chem. 2014. PMID: 25225600 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- DK-056762/DK/NIDDK NIH HHS/United States
- DK-057880/DK/NIDDK NIH HHS/United States
- DK-060720/DK/NIDDK NIH HHS/United States
- DK-67629/DK/NIDDK NIH HHS/United States
- GM-62890/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous